Read more
Dieses Referenzwerk bietet einen vollständigen Überblick über die verschiedenen Phasen der Wirkstoffentwicklung und greift dabei auf einen translationalen Ansatz zurück.
List of contents
Cancer BiomarkersInflammatory and Immunological BiomarkersMetabolic phenotypingNeurological BiomarkersProtein BiomarkersTranslation of Biomarkers into Clinical PracticeAntibody Molecules, Genetic Engineering of Genetic Engineering of HemoglobinGenetic Engineering of VaccinesPharmacology and Emerging Clinical Application of RNAPlant-based Expression of BiopharmaceuticalsRNAi Gene Therapy to Combat HIV-1 Infection RNAi to Treat Chronic Hepatitis B Virus Infection RNAi to Treat Chronic Hepatitis C Infection Sex Hormones (Male): Analogs and AntagonistsSomatic Gene TherapyVaccine Research and DevelopmentBiotransformations of Drugs and ChemicalsDrug Bioavailability, Distribution and Clearance Prediction Microbial Metagenomics and Drug Bioavailability, Toxicity and EfficacyPharmacokinetics and Pharmacodynamics of Biotech Drugs Liposome Gene TransfectionNanometer-scale Polymers for Enhancing Drug DeliveryPhysical Pharmacy and BiopharmaceuticsPreclinical Form & Formulation for Drug DiscoveryTargeting and Intracellular Delivery of DrugsTransporters in Translational MedicineVaccination, GeneticVector Targeting in Gene TherapyVirus-free Gene Transfer systems in Somatic Gene TherapyAlzheimer's Disease Drug DevelopmentAntisense Oligonucleotides as Potential DrugsArtificial Organs and Tissues for Drug DiscoveryBiomarkers in oncology drug development Exploiting Model Organisms for Disease InterventionGeneric versions of therapeutic proteins (Biosimilars) Approaches and ProblemsHIV Prevention Pharmaceuticals Development (pre-exposure prophylaxis (PrEP). )Natural Products Based Drug DiscoveryNucleic Acid Metabolism and Drug DiscoveryOrganic Chemistry in Drug DiscoveryPharmacogenomics and Drug DesignPredictive Drug SafetyReceptor Targets in Drug DiscoveryStructure-based Drug Design and NMR-based ScreeningTherapeutic Compounds in Nature as Leads for New PharmaceuticalsTriacylglycerol Storage and Mobilization, Storage ofTuberculosis Drug DevelopmentCombinations of Agents for the Diagnosis, Therapeutic or Prognosis TestingExperimental Design, Conduct, and Analysis of Clinical TrialsNovel Therapeutics for Targeting PainAnalysis and Pharmaceutical QualityBioprocess EngineeringPharmaceutical Process ChemistryProduction and Commercialization of new Biotechnology Based PharmaceuticalsXenotransplantation in Pharmaceutical BiotechnologyAntibody-enabled small-molecule drug discoveryAntimalarial Drug DiscoveryDiscovery and Development of Small Molecule Cancer Drugs High-throughput behavioral profiling to discover and Characterize Psychotropic DrugsHit-to-Lead Medicinal Chemistry
About the author
Robert A. Meyers obtained his Ph.D. in Chemistry at the University of California at Los Angeles. He was a post-doctoral fellow at the California Institute of Technology and has more than 17 patents, 50 technical papers and 12 books to his name. As Editor-in-Chief he conceived and edited several ambitious multivolume reference works.
Summary
Dieses Referenzwerk bietet einen vollständigen Überblick über die verschiedenen Phasen der Wirkstoffentwicklung und greift dabei auf einen translationalen Ansatz zurück.
